0% found this document useful (0 votes)
133 views2 pages

PDF

This document contains the results of newborn screening tests for several genetic disorders. The tests found that all analytes were within normal ranges. As a result, the sample screened negative for the disorders tested. However, the screening does have limitations and a negative result does not rule out all possibilities. Ongoing monitoring of the baby's health is still recommended.

Uploaded by

Mohammed Fasil
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
133 views2 pages

PDF

This document contains the results of newborn screening tests for several genetic disorders. The tests found that all analytes were within normal ranges. As a result, the sample screened negative for the disorders tested. However, the screening does have limitations and a negative result does not rule out all possibilities. Ongoing monitoring of the baby's health is still recommended.

Uploaded by

Mohammed Fasil
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

CRM NO Name Package Ethnicity

180324400797 B/o. RAIHANA MUNA (TCC25236) BS 7 Asian


Lab ID Father Name Gender Age
80039256 - MALE 2 Days
Gestation(Weeks) Pre Term / Full Term Breast Feed Hospital name
38 Full term YES Cradle Calicut Maternity Care
Pvt. Ltd
Baby Weight (Kg) Specimen Notes Date of Mother Feed Referred By
3.320 Acceptable 14/01/2019 02:00 Dr. NIHAZ NAHA
Type of Pregnancy Specimen Source Collection Date & Time Date of Report & time
Single Heel Prick 16/01/2019 00:00 22/01/2019 21:37
City Baby Admitted on NICU Date of Birth & Time Received Date & Time
Calicut NO 14/01/2019 00:00 22/01/2019 09:50
Collected by Blood Transfusion Is Baby On IV Fluids TPN Feed
ANILA ALWIN NO NO NO
Recall Sample Transfusion Date Bottle Feed Consanguineous Marriage
NO NO NO NO

Initial Report Y Duplicate Report Revision Report Version No 1

SUMMARY
Observations:
All the analytes are within the normal range.

Interpretation:
The tested sample is screened NEGATIVE for the list of disorders tabulated in page 2.

Recommendation:
Please correlate the results with other clinical and diagnostic findings.

CRM NO : 180324400797
Name : B/o. RAIHANA MUNA (TCC25236)

Dr. Sreedhar Mayavan Ph.D Dr. Madan Gopal R M.D.


Laboratory - Head Consultant Biochemist

Page 1 of 2
SCREENING REPORT METHOD: TIME-RESOLVED FLOUROIMMUNOASSAY

Disorder Parameter Result* Result Value Reference Remarks

Congenital Adrenal 17-OHP 6.1 NMT 64 nmol/L Normal


Hyperplasia
Congenital TSH <1.31 NMT 20 µU/mL Normal
Hypothyroidism
Glucose 6 Phosphate G6PD 40.0 NLT 7 U/dL Normal
Dehydrogenase
deficiency
Cystic Fibrosis IRT 16.6 NMT 130 ng/mL Normal
Profound Biotinidase BTD 225.5 NLT 15 U/dL Normal
deficiency
Phenylketonuria PHE 66.61 NMT 250 µmol/L Normal
Classical Galactosemia T GAL <1.15 NMT 15 mg/dL Normal

* This Graph represents the value corresponding to results values. Each box represents the reference value. Results value is shown as red dot.
* NMT - Not More Than, NLT - Not Less Than.
17-OHP - 17a-OH-progesterone, TSH - Thyroid Stimulating Hormone, G6PD - Glucose-6-Phosphate Dehydrogenase, IRT - Human Immunoreactive Trypsin(ogen), BTD -
Profound Biotinidase, PHE - Phenylalanine, T GAL - Total Galactose (galactose and galactose-1-phosphate)

DISCLAIMER
All investigations have their limitations which are imposed by the limits of A negative screening assay result does not rule out the possibility of an
sensitivity and specificity of individual assay procedures as well as the quality of underlying metabolic / genetic disease.
specimen received by the laboratory.
The metabolites and health conditions mapping is not mutually unique and there
It is presumed that the received specimen belongs to the patient named or can be other forms in which an abnormality may be apparent. Similarly, the
identified in the test request form. health condition may not exclusively be an outcome of the disorders in
consideration.
Tests parameters marked by single asterisks are performed in referral laboratory.
Baby Shield 7 tests a sample for limited metabolites markers and their effects on
Partial reproduction of this report is not permitted. human health.

It is important to monitor baby's health and take a proactive approach should Baby Shield 7 test is not intended to replace the medical adv ice and or treatment
there be any unhealthy condition(s) within or beyond scope of this test. obtained from a qualified healthcare practitioner.

REFERENCES
1. Werder, E.A., Siebenmann, R.E., Knorr-Müsset, G., Zimmermann, A., Sizonenko, P.C., Theintz, P., Girard, J., Zachmann, M. and Prader A. (1980): The
incidence of congenital adrenal hyperplasia in Switzerland - A survey of patients born in 1960 to 1974. Helv. Paediat. Acta 35, 5ʹ11.
2. Höller, W., Scholz, S., Knorr, D., Bidlingmaier, F., Keller, E., and Albert, E.D. (1985): Genetic differences between the salt- wasting, simple virilizing and
non-classical types of congenital adrenal hyperplasia. J. Clin. Endrocrinol. Metab. 60, 757ʹ763.
3. Wolf, B. (2012): Biotinidase deficiency: ͞if you have to have an inherited metabolic disease, this is the one to have͘͟Genet. Med.,14, (6), 565ʹ575.

** End Of Report **

CRM NO : 180324400797
Name : B/o. RAIHANA MUNA (TCC25236)

Dr. Sreedhar Mayavan Ph.D Dr. Madan Gopal R M.D.


Laboratory - Head Consultant Biochemist

Page 2 of 2

You might also like